No takes yet. Share an insight, caveat, or question.
Randomized trial assesses interventions to enhance adherence to iron chelation therapy in sickle cell disease and thalassaemia, suggesting need for real-world studies.
Fortin et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: